Highlights from ACR Convergence 2024: Groundbreaking LRA-Funded Research and Innovative Therapies
December 5, 2024 —
The Lupus Research Alliance (LRA) is proud to showcase the groundbreaking work of its funded researchers...
January 16, 2020
Up to half of people with lupus will have lupus nephritis – damage to the kidneys that affects the ability to clear the body of wastes and toxins. In 2020, we expect to see significant progress in new drug development for lupus and lupus nephritis in particular with submissions for FDA approval in progress and many opportunities to join studies exploring other potential treatments!
Click here for lupus nephritis trials to explore with your physician.